• Public website
• Student website
• Staff website
• Organisational structure
• Library website

175 search results for “titel therapy” in the Staff website

• 
  Jessy Terpstra Guest

  Social & Behavioural Sciences

  j.a.terpstra@fsw.leidenuniv.nl | +31 71 527 2727

• 
  Erica Bohnen Guest

  Social & Behavioural Sciences

  e.a.h.bohnen@fsw.leidenuniv.nl | 071 5273381

• 
  Douwe Atsma Professor Cardiology, in particular innovative cardiovascular concepts of care

  Faculteit Geneeskunde

  d.e.atsma@lumc.nl | +31 70 526 2020

• Developing new therapies to fight muscle disease News - 26 September 2022

  Biophysicist Alireza Mashaghi and his collaborators are taking up the fight against muscular dystrophy: genetic disorders that cause muscle weakness. They want to inhibit the clumping of proteins that results in toxic aggregates. For this, the team receives 550,000 euros from Health Holland. The team…

• Discover the Oncode Accelerator research funds for cancer therapies Announcement - 4 November 2024

  Research

• Oncode Accelerator funds preclinical development of cancer therapies News - 23 October 2024

  Through its Demonstrator Projects, the Dutch Oncode Accelerator consortium provides grants for preclinical cancer therapy development. The first call for these projects is open until September 2025.

• LUMC signs international agreement on developing Advanced Therapy Medicinal Products News - 13 October 2022

  Skåne University Hospital, Lund University and Leiden University Medical Center will work together to expand their research, teaching and development relating to Advanced Therapy Medicinal Products. That is the essence of a Memorandum of Understanding signed at SciLifeLab near Stockholm on Wednesday…

• Special nanoparticles for cancer therapy! Will you help? News - 8 September 2022

  Developing a better treatment for patients with head and neck cancer, that is what Binanox, The 2022 iGEM Leiden team, want to achieve. They hope to raise at least 10,000 euros for this cause. Support their crowdfunding campaign today.

• A future with tailored therapy for patients with atherosclerosis News - 11 September 2025

  The AtheroNeth consortium received €6 million from the Dutch Heart Foundation to gain a better understanding of the differences in disease progression among patients with atherosclerosis. The ultimate goal is to enable personalised treatment.

• 
  Femke Stad Assistant Professor

  Social & Behavioural Sciences

  f.e.stad@fsw.leidenuniv.nl | +31 71 527 6790

• 
  Katja Cardol Lecturer

  Social & Behavioural Sciences

  c.k.cardol@fsw.leidenuniv.nl | +31 71 527 5697

• 
  Danielle Oprel

  Social & Behavioural Sciences

  d.a.c.oprel@fsw.leidenuniv.nl | +31 71 527 2727

• 
  Thomas Willems PhD candidate

  Social & Behavioural Sciences

  t.r.a.willems@fsw.leidenuniv.nl | +31 71 527 2727

• patient in the Netherlands successfully treated with stem cell gene therapy News - 22 June 2022

  Researchers from the Leiden University Medical Center (LUMC) have successfully used stem cell gene therapy to treat a baby with the severe congenital immune disorder SCID. An important milestone: it is the first time stem cell gene therapy of Dutch origin has been administered to a patient, and also…

• 
  Marike Kooistra Researcher

  Social & Behavioural Sciences

  m.j.kooistra@fsw.leidenuniv.nl | 071 5272727

• 
  Rianne de Kleine Assistant professor

  Social & Behavioural Sciences

  r.a.de.kleine@fsw.leidenuniv.nl | +31 71 527 5435

• 
  Veronica Janssen Guest employee

  Social & Behavioural Sciences

  v.r.janssen@fsw.leidenuniv.nl | +31 71 527 2727

• 
  David Heyne Guest

  Social & Behavioural Sciences

  d.heyne@fsw.leidenuniv.nl | +31 71 527 2727

• 
  Mona Shahab PhD candidate

  Social & Behavioural Sciences

  m.k.shahab@fsw.leidenuniv.nl | 071 5272727

• ‘Exposure therapy’ for bachelor students: preparing for the reality of scientific research News - 10 October 2024

  Already during their bachelor’s programme, students in Pharmaceutical Sciences are presented with challenging projects. One of these is the Bachelor Research Assignment (BOO in Dutch), which is often their first real experience with scientific research. This means a lot of responsibility and failures,…

• 
  Bianca Boyer Associate professor

  Social & Behavioural Sciences

  b.e.boyer@fsw.leidenuniv.nl | +31 71 527 2727

• 
  Lioe-Fee de Geus-Oei Professor Radiology

  Faculteit Geneeskunde

  l.f.de_geus-oei@lumc.nl | +31 71 526 9111

• 
  Judith Bovée Professor Pathology, in particular the pathology of bone- and soft tissue tumors

  Faculteit Geneeskunde

  j.v.m.g.bovee@lumc.nl | +31 71 526 9111

• 
  Mara van Osch Researcher

  Social & Behavioural Sciences

  m.van.osch@fsw.leidenuniv.nl | 071 5272727

• 
  Oana Georgiana Rus-Oswald Researcher

  Social & Behavioural Sciences

  o.g.rus@fsw.leidenuniv.nl | 071 5272727

• Leiden scientists join national effort to advance nanomedicine News - 10 July 2025

  A Dutch consortium has received €6.7 million to accelerate the development of nanomedicines together with patients. Researchers from Leiden University play a key role in the project.

• 
  Willem van der Does Professor of Clinical Psychology

  Social & Behavioural Sciences

  vanderdoes@fsw.leidenuniv.nl | 071 5272727

• 
  Nina Komrij Postdoc

  Social & Behavioural Sciences

  n.l.komrij@fsw.leidenuniv.nl | 071 5272727

• Webinar Transfusion Medicine and Cellular and Tissue Therapies Event - 4 November 2024

  Study information

• Webinar Transfusion Medicine and Cellular and Tissue Therapies Event - 18 March 2025

  Study information

• Is a cancer pill a matter of time? News - 21 February 2022

  A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.

• 
  Philip Spinhoven Professor emeritus Clinical Psychology

  Social & Behavioural Sciences

  spinhoven@fsw.leidenuniv.nl | 071 5272727

• 
  Sylvestre Bonnet Professor Bioinorganic chemistry

  Faculty of Science

  bonnet@chem.leidenuniv.nl | +31 71 527 4260

• 
  John Haanen Professor Translational immunotherapy of cancer

  Faculteit Geneeskunde

  j.haanen@nki.nl | +31 71 526 3057

• 
  Rick Haas Professor by special appointment Radiotherapy, in particular of bone and soft tissue sarcomas

  Faculteit Geneeskunde

  r.l.m.haas@lumc.nl | +31 71 526 9111

• 
  Eveline Bleiker Professor by special appointment Psychology of clinical genetics, in particular oncogenetics

  Faculteit Geneeskunde

  e.bleiker@nki.nl | +31 71 526 8033

• 
  Alfred Vertegaal Professor Cell Biology, in particular of post-translational modification of proteins

  Faculteit Geneeskunde

  vertegaal@lumc.nl | +31 71 526 9111

• 
  Marjanka Schmidt Professor by special appointment Genetic Epidemiology of cancer

  Faculteit Geneeskunde

  m.k.schmidt@lumc.nl | +31 71 526 9111

• 
  Jeroen Jansen Professor Otorhinolaryngology

  Faculteit Geneeskunde

  j.c.jansen@lumc.nl | +31 71 5 26 91 11

• Health insurance Collective insurances

  If you wish, you can take part in the collective health insurance scheme offered by Leiden University and Zorg en Zekerheid. This scheme offers a collective discount, for you and your family.

• 
  Joan Hendrik Veelken Professor Internal Medicine, in particular hematology

  Faculteit Geneeskunde

  j.h.veelken@lumc.nl | +31 71 526 2267

• 
  Jelle Wesseling Professor by special appointment Pathology, in particular breast pathology

  Faculteit Geneeskunde

  j.wesseling@nki.nl | +31 71 526 6622

• 
  Coen Rasch Professor Radiotherapy, in particular translational radiotherapy

  Faculteit Geneeskunde

  c.r.n.rasch@lumc.nl |

• 
  Johanneke Portielje Professor of Internal Medicine, in particular Geriatric Oncology

  Faculteit Geneeskunde

  j.e.a.portielje@lumc.nl | +31 71 526 3464

• 
  Monique van Leerdam Professor Gastroenterology and Hepatology

  Faculteit Geneeskunde

  m.v.leerdam@nki.nl | +31 71 526 9111

• 
  J Morreau Professor Pathology, in particular the molecular pathology of hereditary tumours

  Faculteit Geneeskunde

  j.morreau@lumc.nl | +31 71 526 6630

• 
  Hans Gelderblom Professor Internal Medicine, in particular medical oncology

  Faculteit Geneeskunde

  a.j.gelderblom@lumc.nl | +31 71 526 3486

• 
  Karin de Visser Professor by special appointment Tumor Immunology

  Faculteit Geneeskunde

  k.e.de_visser@lumc.nl |

• 
  Hans Vasen Professor emeritus Prevention of hereditary tumours

  Faculteit Geneeskunde

  h.f.a.vasen@lumc.nl |

• 
  Rob Pelger Professor Emeritus Urology

  Faculteit Geneeskunde

  r.c.m.pelger@lumc.nl |